Role of dopamine in non-depressed patients with a history of suicide attempts

European Psychiatry

Volumn 16, Issue 7, 2001, Pages 424-427

  Pitchot, W ^a   Hansenne, M ^a   Ansseau, M ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Depression; Dopamine; Monoamine; Suicide

Indexed keywords

APOMORPHINE;

AGGRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG EFFECT; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SUICIDE; SUICIDE ATTEMPT;

EID: 0035184322     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(01)00601-0     Document Type: Article

References (24)

1. Life at risk: Markers of suicidality in depression
2. Concurrent use of REM latency, dexamethasone suppression, clonidine and apomorphine tests as biological markers of endogenous depression
3. Serotonergic, noradrenergic, and dopaminergic measures in suicide brains
4. Determination of monoamine and monoamine metabolites in the human brain: Postmortem studies in a group of suicides and in a control group
5. Reduced dopamine turnover in the basal ganglia of depressed suicides
6. Neurotransmitter receptors and monoamine metabolites in the brains of patients with alzheimer-type dementia and depression and suicides
7. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls
8. Le dosage radioimmunologique de l'hormone de croissance humaine
9. A rating scale for depression
10. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients
11. Pharmacological prevention of suicidal behavior
12. Serotonergic measures in suicide brain: The concentration of 5-HIAA, HVA, and tryptophan in frontal cortex of suicide victims
13. Suicidal behavior and growth hormone response to apomorphine test
14. Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts
15. Effect of previous antidepressant therapy on the growth hormone response to apomorphine
16. Reduced dopaminergic activity in depressed suicides
17. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindolacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression
18. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: A 5-years follow-up study
19. Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide
20. Are cerebrospinal fluid or urinary monoamine metabolite measures stronger correlates of suicidal behavior in depression?
21. Monoamine metabolites in CSF and suicidal behavior
22. The role of monoamines in suicidal behavior